VCAM-1 and its functions in development and inflammatory diseases

  • Sharon J. Hyduk
  • Myron I. Cybulsky
Part of the Progress in Inflammation Research book series (PIR)


VCAM-1 was identified in endothelium by monoclonal antibody and expression cloning approaches [1, 2, 3] . These approaches, as well as the discovery of other endothelial cell adhesion molecules, were dependent on the development of efficient and reproducible techniques for culturing human umbilical vein endothelial cells, and on observations that treatment with inflammatory cytokines, such as interleukin-1 (IL-1) and tumor necrosis factor-α (TNF), or with bacterial endotoxin resulted in endothelial activation [4]. Cytokine activation alters the phenotype of quiescent endothelial cells, resulting in a protein synthesis-dependent hyperadhesive state for leukocytes. The monoclonal antibody studies involved immunizing mice with activated endothelium and screening for monoclonal antibodies that recognized cytokine-inducible epitopes. The antibodies were then used to identify unique proteins by immunoprecipitation and leukocyte adhesion function was ascertained by antibody adhesion-blocking assays. Expression cloning used a subtracted cytokine-activated human umbilical vein endothelial cell library packaged in a eukaryotic expression vector that was transiently expressed in transfected COS cells, and cDNA from cells exhibiting increased leukocyte adhesion was extracted amplified, retransfected and rescreened [3].


Vascular Cell Adhesion Arterioscler Thromb Vasc Biol Cardiac Allograft Vasculopathy Integrin Affinity Adhesion Strengthen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rice GE, Bevilacqua MP (1989) An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246: 1303–1306PubMedGoogle Scholar
  2. 2.
    Carlos TM, Schwartz BR, Kovach NL, Yee E, Rosa M, Osborn L, Chi-Rosso G, Newman B, Lobb R, Harlan JM (1990) Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells [published erratum appears in Blood (1990) 76: 2420]. Blood 76: 965–970PubMedGoogle Scholar
  3. 3.
    Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R (1989) Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59: 1203–1211PubMedGoogle Scholar
  4. 4.
    Pober JS, Cotran RS (1990) Cytokines and endothelial cell biology. Phystol Rev 70: 427–451Google Scholar
  5. 5.
    Cybulsky MI, Fries JW, Williams AJ, Sultan P, Davis VM, Gimbrone MA Jr, Collins T (1991) Alternative splicing of human VCAM-1 in activated vascular endothelium. Am J Pathol 138: 815–820PubMedGoogle Scholar
  6. 6.
    Hession C, Tizard R, Vassallo C, Schiffer SB, Goff D, Moy P, Chi-Rosso G, Luhowskyj S, Lobb R, Osborn L (1991) Cloning of an alternate form of vascular cell adhesion molecule-1 (VCAM1). J Biol Chem 266: 6682–6685PubMedGoogle Scholar
  7. 7.
    Polte T, Newman W, Raghunathan G, Gopal TV (1991) Structural and functional studies of full-length vascular cell adhesion molecule-1: internal duplication and homology to several adhesion proteins. DNA Cell Biol 10: 349–357PubMedGoogle Scholar
  8. 8.
    Cybulsky MI, Fries JW, Williams AJ, Sultan P, Eddy R, Byers M, Shows T, Gimbrone MA Jr, Collins T (1991) Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene. Proc Natl Acad Sci USA 88: 7859–7863PubMedGoogle Scholar
  9. 9.
    Cybulsky MI, Allan-Motamed M, Collins T (1993) Structure of the murine VCAM1 gene. Genomics 18: 387–391PubMedGoogle Scholar
  10. 10.
    Osborn L, Vassallo C, Browning BG, Tizard R, Haskard DO, Benjamin CD, Dougas I, Kirchhausen T (1994) Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1). J Cell Biol 124: 601–608PubMedGoogle Scholar
  11. 11.
    Vonderheide RH, Tedder TF, Springer TA, Staunton DE (1994) Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4. J Cell Biol 125: 215–222PubMedGoogle Scholar
  12. 12.
    Moy P, Lobb R, Tizard R, Olson D, Hession C (1993) Cloning of an inflammationspecific phosphatidyl inositol-linked form of murine vascular cell adhesion molecule-1. J Biol Chem 268: 8835–8841PubMedGoogle Scholar
  13. 13.
    Terry RW, Kwee L, Levine JF, Labow MA (1993) Cytokine induction of an alternatively spliced murine vascular cell adhesion molecule (VCAM) mRNA encoding a glycosylphosphatidylinositol-anchored VCAM protein. Proc Natl Acad Sci USA 90: 5919–5923PubMedGoogle Scholar
  14. 14.
    Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR (1990) VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60: 577–584PubMedGoogle Scholar
  15. 15.
    Grayson MH, Van der Vieren M, Sterbinsky SA, Michael Gallatin W, Hoffman PA, Staunton DE, Bochner BS (1998) αdß2 integrin is expressed on human eosinophils and functions as an alternative ligand for vascular cell adhesion molecule 1 (VCAM-1). J Exp Med 188: 2187–2191PubMedGoogle Scholar
  16. 16.
    Taooka Y, Chen J, Yednock T, Sheppard D (1999) The integrin α9ßl mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol 145: 413–420PubMedGoogle Scholar
  17. 17.
    Van der Vieren M, Crowe DT, Hoekstra D, Vazeux R, Hoffman PA, Grayson MH, Bochner BS, Gallatin WM, Staunton DE (1999) The leukocyte integrin αdß2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1. J Immunol 163:1984–1990PubMedGoogle Scholar
  18. 18.
    Kelly KA, Allport JR, Yu AM, Sinh S, Sage EH, Gerszten RE, Weissleder R (2007) SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration. J Leukoc Biol 81: 748–756PubMedGoogle Scholar
  19. 19.
    Goldblum SE, Ding X, Funk SE, Sage EH (1994) SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc Natl Acad Sci USA 91: 3448–3452PubMedGoogle Scholar
  20. 20.
    Murphy-Ullrich JE, Lane TF, Pallero MA, Sage EH (1995) SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand. J Cell Biochem 57: 341–350PubMedGoogle Scholar
  21. 21.
    Jones EY, Harlos K, Bottomley MJ, Robinson RC, Driscoll PC, Edwards RM, Clements JM, Dudgeon TJ, Stuart DI (1995) Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 A resolution. Nature 373: 539–544PubMedGoogle Scholar
  22. 22.
    Wang JH, Pepinsky RB, Stehle T, Liu JH, Karpusas M, Browning B, Osborn L (1995) The crystal structure of an N-terminal two-domain fragment of vascular cell adhesion molecule 1 (VCAM-1): a cyclic peptide based on the domain 1 C-D loop can inhibit VCAM-1-alpha 4 integrin interaction. Proc Natl Acad Sci USA 92: 5714–5718PubMedGoogle Scholar
  23. 23.
    Wang J, Springer TA (1998) Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses. Immunol Rev 163: 197–215PubMedGoogle Scholar
  24. 24.
    Hoffmann A, Baltimore D (2006) Circuitry of nuclear factor kappaB signaling. Immunol Rev 210:171–186PubMedGoogle Scholar
  25. 25.
    Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49–62PubMedGoogle Scholar
  26. 26.
    Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokineinducible enhancers. FASEB J 9: 899–909PubMedGoogle Scholar
  27. 27.
    Iademarco MF, McQuillan JJ, Rosen GD, ean DC (1992) Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 267: 16323–16329PubMedGoogle Scholar
  28. 28.
    Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T (1992) Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 176: 1583–1593PubMedGoogle Scholar
  29. 29.
    Neish AS, Khachigian LM, Park A, Baichwal VR, Collins T (1995) Sp1 is a component of the cytokine-inducible enhancer in the promoter of vascular cell adhesion molecule-1. J Biol Chem 270: 28903–28909PubMedGoogle Scholar
  30. 30.
    Neish AS, Read MA, Thanos D, Pine R, Mamatis T, Collins T (1995) Endothelial mterferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 15: 2558–2569PubMedGoogle Scholar
  31. 31.
    Lechleitner S, Gille J, Johnson DR, Petzelbauer P (1998) Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon-related factor 1-dependent pathway. J Exp Med 187: 2023–2030PubMedGoogle Scholar
  32. 32.
    Ochi H, Masuda J, Gimbrone MA (2002) Hyperosmotic stimuli inhibit VCAM-1 expression in cultured endothelial cells via effects on interferon regulatory factor-1 expression and activity. Eur J Immunol 32: 1821–1831PubMedGoogle Scholar
  33. 33.
    Ahmad M, Theofanidis P, Medford RM (1998) Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha. J Biol Chem 273: 4616–4621PubMedGoogle Scholar
  34. 34.
    Inoue K, Kobayashi M, Yano K, Miura M, Izumi A, Mataki C, Doi T, Hamakubo T, Reid PC, Hume DA et al (2006) Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression. Arterioscler Thromb Vasc Biol 26: 2652–2659PubMedGoogle Scholar
  35. 35.
    dela Paz NG, Simeonidis S, Leo C, Rose DW, Collins T (2007) Regulation of NF-kap-paB-dependent gene expression by the POU domain transcription factor Oct-1. J Biol Chem 282: 8424–8434Google Scholar
  36. 36.
    Schwachtgen JL, Remacle JE, Janel N, Brys R, Huylebroeck D, Meyer D, KerbiriouNabias D (1998) Oct-1 is involved in the transcriptional repression of the von Willebrand factor gene promoter. Blood 92: 1247–1258PubMedGoogle Scholar
  37. 37.
    Masinovsky B, Urdal D, Gallatin WM (1990) IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J Immunol 145: 2886–2895PubMedGoogle Scholar
  38. 38.
    Thornhill MH, Haskard DO (1990) IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. J Immunol 145: 865–872PubMedGoogle Scholar
  39. 39.
    Iademarco MF, Barks JL, Dean DC (1995) Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J Clin Invest 95: 264–271PubMedGoogle Scholar
  40. 40.
    Lee YW, Kuhn H, Hennig B, Neish AS, Toborek M (2001) IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. J Mol Cell Cardiol 33: 83–94PubMedGoogle Scholar
  41. 41.
    Schmidt AM, Hori O, Cao R, Yan SD, Brett J, Wautier JL, Ogawa S, Kuwabara K, Matsumoto M, Stern D (1996) RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45: S77–80Google Scholar
  42. 42.
    Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BSet al (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91: 3527–3561PubMedGoogle Scholar
  43. 43.
    Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A 1995 Expression of functional CD40 by vascular endothelial cells. J Exp Med 182: 33–40PubMedGoogle Scholar
  44. 44.
    Karmann K, Hughes CC, Schechner J, Fanslow WC, Pober JS (1995) CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sä USA 92: 4342–4346Google Scholar
  45. 45.
    Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, Chess L (1995) Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med 182: 1857–1864PubMedGoogle Scholar
  46. 46.
    Kume N, Cybulsky MI, Gimbrone MA Jr (1992) Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90: 1138–1144PubMedGoogle Scholar
  47. 47.
    Kawakami A, Aikawa M, Alcaide P, Luscinskas FW, Libby P, Sacks FM (2006) Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation 114: 681–687PubMedGoogle Scholar
  48. 48.
    Silverman MD, Tumuluri RJ, Davis M, Lopez G, Rosenbaum JT, Lelkes PI (2002) Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler Thromb Vasc Biol 22: 587–592PubMedGoogle Scholar
  49. 49.
    Khreiss T, Jozsef L, Potempa LA, Filep JG (2004) Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 109: 2016–2022PubMedGoogle Scholar
  50. 50.
    Minami T, Miura M, Aird WC, Kodama T (2006) Thrombin-induced autoinhibitory factor, Down syndrome critical region-1, attenuates NFAT-dependent vascular cell adhesion molecule-1 expression and inflammation in the endothelium. J Biol Chem 281: 20503–20520PubMedGoogle Scholar
  51. 51.
    Minami T, Aird WC (2001) Thrombin stimulation of the vascular cell adhesion molecule-1 promoter in endothelial cells is mediated by tandem nuclear factor-kappa B and GATA motifs. J Biol Chem 276: 47632–47641PubMedGoogle Scholar
  52. 52.
    Minami T, Abid MR, Zhang J, King G, Kodama T, Aird WC (2003) Thrombin stimulation of vascular adhesion molecule-1 in endothelial cells is mediated by protein kinase C (PKC)-delta-NF-kappa B and PKC-zeta-GATA signaling pathways. J Biol Chem 278: 6976–6984PubMedGoogle Scholar
  53. 53.
    Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM(1993) Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92: 1866–1874PubMedGoogle Scholar
  54. 54.
    Weber C, Erl W, Pietsch A, Strobe M, Ziegler-Heitbrock HW, Weber PC (1994) Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb14: 1665–1673PubMedGoogle Scholar
  55. 55.
    Ferrante A, Robinson BS, Singh H, Jersmann HP, Ferrante JV, Huang ZH, Trout NA, Pitt MJ, Rathjen DA, Easton CJ et al (2006) A novel beta-oxa polyunsaturated fatty acid downregulates the activation of the IkappaB kinase/nuclear factor kappaB pathway, inhibits expression of endothelial cell adhesion molecules, and depresses inflammation. Circ Res 99: 34–41PubMedGoogle Scholar
  56. 56.
    Spiecker M, Peng HB, Liao JK (1997) Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J Biol Chem 272: 30969–30974PubMedGoogle Scholar
  57. 57.
    Murase T, Kume N, Hase T, Shibuya Y, Nishizawa Y, Tokimitsu I, Kita T (1999) Gallates inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of leukocyte adhesion molecules in vascular endothelial cells. Arterioscler Thromb Vasc Biol 19: 1412–1420PubMedGoogle Scholar
  58. 58.
    Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T (1995) The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 2: 493–506PubMedGoogle Scholar
  59. 59.
    De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96: 60–68PubMedGoogle Scholar
  60. 60.
    Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM (1996) Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA 93: 9114–9119PubMedGoogle Scholar
  61. 61.
    Ramana KV, Bhatnagar A, Srivastava SK (2004) Inhibition of aldose reductase attenuates TNF-alpha-induced expression of adhesion molecules in endothelial cells. FASEB J 18:1209–1218PubMedGoogle Scholar
  62. 62.
    Tummala PE, Chen XL, Medford RM (2000) NF-kappa B independent suppression of endothelial vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 gene expression by inhibition of flavin binding proteins and Superoxide production. J Mol Cell Cardiol 32: 1499–1508PubMedGoogle Scholar
  63. 63.
    Kunsch C, Luchoomun J, Grey JY, O’lliff LK, Saint LB, Arrendale RF, Wasserman MA, Saxena U, Medford RM (2004) Selective inhibition of endothelial and monocyte redoxsensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent. J Pharmacol Exp Ther 308: 820–829PubMedGoogle Scholar
  64. 64.
    Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, Visioli F, Distante A, De Caterina R (2003) Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 23: 622–629PubMedGoogle Scholar
  65. 65.
    Mukherjee TK, Nathan L, Dinh H, Reddy ST, Chaudhuri G (2003) 17-epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression. J Biol Chem 278: 11746–11752PubMedGoogle Scholar
  66. 66.
    Pasceri V, Wu HD, Willerson JT, Yeh ET (2000) Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation 101:235–238PubMedGoogle Scholar
  67. 67.
    Wang N, Verna L, Chen NG, Chen J, Li H, Forman BM, Stemerman MB (2002) Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J Biol Chem 277: 34176–34181PubMedGoogle Scholar
  68. 68.
    Ahmed W, Orasanu G, Nehra V, Asatryan L, Rader DJ, Ziouzenkova O, Plutzky J (2006) High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion. Circ Res 98: 490–498PubMedGoogle Scholar
  69. 69.
    Ziouzenkova O, Perrey S, Asatryan L, Hwang J, MacNaul KL, Moller DE, Rader DJ, Sevanian A, Zechner R, Hoefler G, Plutzky J (2003) Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase. Proc Natl Acad Sci USA 100: 2730–2735PubMedGoogle Scholar
  70. 70.
    De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P (1994) The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 14:1829–1836PubMedGoogle Scholar
  71. 71.
    Besemer J, Harant H, Wang S, Oberhauser B, Marquardt K, Foster CA, Schreiner EP, de Vries JE, Dascher-Nadel C, Lindley IJ (2005) Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1. Nature 436: 290–293PubMedGoogle Scholar
  72. 72.
    Gimbrone MA Jr, Nagel T, Topper JN (1997) Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Invest 100: S61–65Google Scholar
  73. 73.
    Topper JN, Cai J, Falb D, Gimbrone MA Jr (1996) Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese Superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci USA 93: 10417–10422PubMedGoogle Scholar
  74. 74.
    Dai G, Kaazempur-Mofrad MR, Natarajan S, Zhang Y, Vaughn S, Blackman BR, Kamm RD, Garcia-Cardena G, Gimbrone MA Jr (2004) Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and-resistant regions of human vasculature. Proc Natl Acad Sci USA 101: 14871–14876PubMedGoogle Scholar
  75. 75.
    Hajra L, Evans AI, Chen M, Hyduk SJ, Collins T, Cybulsky MI (2000) The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci USA 97: 9052–9057PubMedGoogle Scholar
  76. 76.
    Nagel T, Resnick N, Atkinson WJ, Dewey CF Jr, Gimbrone MA Jr (1994) Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest 94: 885–891PubMedGoogle Scholar
  77. 77.
    Ando J, Tsuboi H, Korenaga R, Takada Y, Toyama-Sorimachi N, Miyasaka M, Kamiya A (1994) Shear stress inhibits adhesion of cultured mouse endothelial cells to lymphocytes by downregulating VCAM-1 expression. Am J Physiol 267: C679–687PubMedGoogle Scholar
  78. 78.
    Chiu JJ, Lee PL, Chen CN, Lee CI, Chang SF, Chen LJ, Lien SC, Ko YC, Usami S, Chien S (2004) Shear stress increases ICAM-1 and decreases VCAM-1 and E-selectin expressions induced by tumor necrosis factor-[alpha] in endothelial cells. Arterioscler Thromb Vasc Biol 24: 73–79PubMedGoogle Scholar
  79. 79.
    Berk BC, Mm W, Yan C, Surapisitchat J, Liu Y, Hoefen R (2002) Atheroprotective mechanisms activated by fluid shear stress in endothelial cells. Drug News Perspect 15: 133–139PubMedGoogle Scholar
  80. 80.
    Yamawaki H, Pan S, Lee RT, Berk BC (2005) Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest 115: 733–738PubMedGoogle Scholar
  81. 81.
    Parmar KM, Larman HB, Dai G, Zhang Y, Wang ET, Moorthy SN, Kratz JR, Lin Z, Jain MK, Gimbrone MA Jr, Garcia-Cardena G (2006) Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 116: 49–58PubMedGoogle Scholar
  82. 82.
    SenBanerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, Kumar A, Feinberg MW, Chen Z, Simon DI, Luscinskas FW et al (2004) KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 199: 1305–1315PubMedGoogle Scholar
  83. 83.
    Rice GE, Munro JM, Corless C, Bevilacqua MP (1991) Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues. Am J Pathol 138: 385–393PubMedGoogle Scholar
  84. 84.
    Miyake K, Medina K, Ishihara K, Kimoto M, Auerbach R, Kincade PW (1991) A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J Cell Biol 114: 557–565PubMedGoogle Scholar
  85. 85.
    Rosen GD, Sanes JR, La Chance R, Cunningham JM, Roman J, Dean DC (1992) Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell 69: 1107–1119PubMedGoogle Scholar
  86. 86.
    Simmons PJ, Masinovsky B, Longenecker BM, Berenson R, Torok-Storb B, Gallatin WM (1992) Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 80: 388–395PubMedGoogle Scholar
  87. 87.
    Iademarco MF, McQuillan JJ, Dean DC (1993) Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium. Troc Natl Acad Sci USA 90: 3943–3947Google Scholar
  88. 88.
    Jesse TL, La Chance R, Iademarco MF, Dean DC (1998) Interferon regulatory factor-2 is a transcriptional activator in muscle where It regulates expression of vascular cell adhesion molecule-1. J Cell Biol 140: 1265–1276PubMedGoogle Scholar
  89. 89.
    Duplaa C, Couffinhal T, Dufourcq P, Lianas B, Moreau C, Bonnet J (1997) The integrin very late antigen-4 is expressed in human smooth muscle cell. Involvement of alpha 4 and vascular cell adhesion molecule-1 during smooth muscle cell differentiation. Circ Res 80: 159–169PubMedGoogle Scholar
  90. 90.
    Li H, Cybulsky MI, Gimbrone MA Jr, Libby P (1993) Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol 143: 1551–1559PubMedGoogle Scholar
  91. 91.
    Ardehali A, Laks H, Drinkwater DC, Ziv E, Drake TA (1995) Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy. Circulation 91: 450–456Google Scholar
  92. 92.
    Landry DB, Couper LL, Bryant SR, Lindner V (1997) Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. Am J Pathol 151: 1085–1095PubMedGoogle Scholar
  93. 93.
    Lavie J, Dandre F, Louis H, Lamaziere JM, Bonnet J (1999) Vascular cell adhesion molecule-1 gene expression during human smooth muscle cell differentiation is independent of NF-kappaB activation. J Biol Chem 274: 2308–2314PubMedGoogle Scholar
  94. 94.
    Couffinhal T, Duplaa C, Moreau C, Lamaziere JM, Bonnet J (1994) Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res 74: 225–234PubMedGoogle Scholar
  95. 95.
    Braun M, Pietsch P, Felix SB, Baumann G (1995) Modulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 on human coronary smooth muscle cells by cytokines. J Mol Cell Cardiol 27: 2571–2579PubMedGoogle Scholar
  96. 96.
    Barks JL, McQuillan JJ, Iademarco MF (1997) TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J Immunol 159: 4532–4538PubMedGoogle Scholar
  97. 97.
    Wright PS, Cooper JR, Kropp KE, Busch SJ (1999) Induction of vascular cell adhesion molecule-1 expression by IL-4 in human aortic smooth muscle cells is not associated with increased nuclear NF-kappaB levels. J Cell Phystol 180: 381–389Google Scholar
  98. 98.
    Gamble JR, Bradley S, Noack L, Vadas MA (1995) TGF-beta and endothelial cells inhibit VCAM-1 expression on human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 15: 949–955PubMedGoogle Scholar
  99. 99.
    Gurtner GC, Davis V, Li H, McCoy MJ, Sharpe A, Cybulsky MI (1995) Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev 9: 1–14PubMedGoogle Scholar
  100. 100.
    Kwee L, Baldwin HS, Shen HM, Stewart CL, Buck C, Buck CA, Labow MA (1995) Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 121: 489–503PubMedGoogle Scholar
  101. 101.
    Yang JT, Rayburn H, Hynes RO (1995) Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. Development 121: 549–560PubMedGoogle Scholar
  102. 102.
    Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS (2001) A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107: 1255–1262PubMedGoogle Scholar
  103. 103.
    Yang JT, Rando TA, Mohler WA, Rayburn H, Blau HM, Hynes RO (1996) Genetic analysis of alpha 4 integrin functions in the development of mouse skeletal muscle. J Cell Biol 135: 829–835PubMedGoogle Scholar
  104. 104.
    Miyake K, Weissman IL, Greenberger JS, Kincade PW (1991) Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med 173: 599–607PubMedGoogle Scholar
  105. 105.
    Jacobsen K, Kravitz J, Kincade PW, Osmond DG (1996) Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice. Blood 87: 73–82PubMedGoogle Scholar
  106. 106.
    Tada T, Widayati DT, Fukuta K (2006) Morphological study of the transition of haematopoietic sites in the developing mouse during the peri-natal period. Anat Histol Embryol 35: 235–240PubMedGoogle Scholar
  107. 107.
    Leuker CE, M Labow, W Muller, Wagner N (2001) Neonatally induced inactivation of the vascular cell adhesion molecule 1 gene impairs B cell localization and T cell-dependent humoral immune response. J Exp Med 193: 755–768PubMedGoogle Scholar
  108. 108.
    Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, Flavell RA (2001) Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med 193: 741–745PubMedGoogle Scholar
  109. 109.
    Papayannopoulou T, Nakamoto B (1993) Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci USA 90: 9374–9378PubMedGoogle Scholar
  110. 110.
    Funk PE, Kincade PW, Witte PL (1994) Native associations of early hematopoietic stem cells and stromal cells isolated in bone marrow cell aggregates. Blood 83: 361–369PubMedGoogle Scholar
  111. 111.
    Craddock CF, Nakamoto B, Andrews RG, Priestley GV, Papayannopoulou T (1997) Antibodies to VLA4 integrin mobilize long-term repopulating cells and augment cytokine-induced mobilization in primates and mice. Blood 90: 4779–4788PubMedGoogle Scholar
  112. 112.
    Friedrich C, Cybulsky MI, Gutierrez-Ramos JC (1996) Vascular cell adhesion molecule-1 expression by hematopoiesis-supporting stromal cells is not essential for lymphoid or myeloid differentiation in vivo or in vitro. Eur J Immunol 26: 2773–2780PubMedGoogle Scholar
  113. 113.
    Ulyanova T, Scott LM, Priestley GV, Jiang Y, Nakamoto B, Koni PA, Papayannopoulou T (2005) VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin. Blood 106: 86–94PubMedGoogle Scholar
  114. 114.
    Teixido J, Hemler ME, Greenberger JS, Anklesaria P (1992) Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. J Clin Invest 90: 358–367PubMedGoogle Scholar
  115. 115.
    Scott LM, Priestley GV, Papayannopoulou T (2003) Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol 23: 9349–9360PubMedGoogle Scholar
  116. 116.
    Priestley GV, Ulyanova T, Papayannopoulou T (2007) Sustained alterations in biodistribution of stem/progenitor cells in Tie2Cre+ alpha4(f/f) mice are hematopoietic cell autonomous. Blood 109: 109–111PubMedGoogle Scholar
  117. 117.
    Arroyo AG, Yang JT, Rayburn H, Hynes RO (1996) Differential requirements for alpha4 integrins during fetal and adult hematopoiesis. Cell 85: 997–1008PubMedGoogle Scholar
  118. 118.
    Berlin-Rufenach C, Otto F, Mathies M, Westermann J, Owen MJ, Hamann A, Hogg N (1999) Lymphocyte migration in lymphocyte function-associated antigen (LFA)-l-deficient mice. J Exp Med 189: 1467–1478PubMedGoogle Scholar
  119. 119.
    Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301–314PubMedGoogle Scholar
  120. 120.
    Butcher EC, Picker LJ (1996) Lymphocyte homing and homeostasis. Science 272: 60–66PubMedGoogle Scholar
  121. 121.
    Campbell JJ, Butcher EC (2000) Chemokines in tissue-specific and microenvironmentspecific lymphocyte homing. Curr Opin Immunol 12: 336–341PubMedGoogle Scholar
  122. 122.
    Ley K (2001) Pathways and bottlenecks in the web of inflammatory adhesion molecules and chemoattractants. Immunol Res 24: 87–95PubMedGoogle Scholar
  123. 123.
    Alon R, Hammer DA, Springer TA (1995) Lifetime of the P-selectin-carbohydrate bond and its response to tensile force in hydrodynamic flow. Nature 374: 539–542PubMedGoogle Scholar
  124. 124.
    Alon R, Chen S, Puri KD, Finger EB, Springer TA (1997) The kinetics of L-selectin tethers and the mechanics of selectin-mediated rolling. J Cell Biol 138: 1169–1180PubMedGoogle Scholar
  125. 125.
    Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA (1995) The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 128: 1243–1253PubMedGoogle Scholar
  126. 126.
    Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hasslen SR, Nelson RD, Berg EL, Erlandsen SL, Butcher EC (1995) alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80: 413–422PubMedGoogle Scholar
  127. 127.
    Luscinskas FW, Ding H, Lichtman AH (1995) P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor alpha-activated vascular endothelium under flow. J Exp Med 181: 1179–1186PubMedGoogle Scholar
  128. 128.
    Lalor PF, Clements JM, Pigott R, Humphries MJ, Spragg JH, Nash GB (1997) Association between receptor density, cellular activation, and transformation of adhesive behavior of flowing lymphocytes binding to VCAM-1. Eur J Immunol 27: 1422–1426PubMedGoogle Scholar
  129. 129.
    Chen C, Mobley JL, Dwir O, Shimron F, Grabovsky V, Lobb RR, Shimizu Y, Alon R (1999) High affinity very late antigen-4 subsets expressed on T cells are mandatory for spontaneous adhesion strengthening but not for rolling on VCAM-1 in shear flow. J Immunol 162: 1084–1095PubMedGoogle Scholar
  130. 130.
    Vajkoczy P, Laschinger M, Engelhardt B (2001) alpha4-integrin-VCAM-l binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J Clin Invest 108: 557–565PubMedGoogle Scholar
  131. 131.
    Nandi A, Estess P, Siegelman M (2004) Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity 20: 455–465PubMedGoogle Scholar
  132. 132.
    Huo Y, Hafezi-Moghadam A, Ley K (2000) Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ Res 87: 153–159PubMedGoogle Scholar
  133. 133.
    Singbartl K, Thatte J, Smith ML, Wethmar K, Day K, Ley K (2001) A CD2-green fluorescence protein-transgenic mouse reveals very late antigen-4-dependent CD 8+ lymphocyte rolling in inflamed venules. J Immunol 166: 7520–7526PubMedGoogle Scholar
  134. 134.
    Kerfoot SM, Kubes P (2002) Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J Immunol 169: 1000–1006PubMedGoogle Scholar
  135. 135.
    Carman CV, Springer TA (2003) Integrin avidity regulation: are changes in affinity and conformation underemphasized? Curr Opin Cell Biol 15: 547–556PubMedGoogle Scholar
  136. 136.
    Luo BH, Springer TA (2006) Integrin structures and conformational signaling. Curr Opin Cell Biol 18: 579–586PubMedGoogle Scholar
  137. 137.
    Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C, Auer M, Hub E, Rot A (1997) Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91: 385–395PubMedGoogle Scholar
  138. 138.
    Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S (1993) T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 361: 79–82PubMedGoogle Scholar
  139. 139.
    Lloyd AR, Oppenheim JJ, Kelvin DJ, Taub DD (1996) Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J Immunol 156: 932–938PubMedGoogle Scholar
  140. 140.
    Campbell JJ, Qin S, Bacon KB, Mackay CR, Butcher EC (1996) Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells. J Cell Biol 134: 255–266PubMedGoogle Scholar
  141. 141.
    Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC (1998) Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279: 381–384PubMedGoogle Scholar
  142. 142.
    Chan JR, Hyduk SJ, Cybulsky MI (2001) Chemoattractants induce a rapid and transient upregulation of monocyte alpha4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest: an early step in the process of emigration. J Exp Med 193: 1149–1158PubMedGoogle Scholar
  143. 143.
    DiVietro JA, Brown DC, Sklar LA, Larson RS, Lawrence MB (2007) Immobilized stromal cell-derived factor-1 alpha triggers rapid VLA-4 affinity increases to stabilize lymphocyte tethers on VCAM-1 and subsequently initiate firm adhesion. J Immunol 178:3903–3911PubMedGoogle Scholar
  144. 144.
    Grabovsky V, Feigelson S, Chen C, Bleijs DA, Peled A, Cinamon G, Baleux F, Arenzana-Seisdedos F, Lapidot T, van Kooyk Y et al (2000) Subsecond induction of alpha4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J Exp Med 192: 495–506PubMedGoogle Scholar
  145. 145.
    Abitorabi MA, Pachynski RK, Ferrando RE, Tidswell M, Erle DJ (1997) Presentation of integrins on leukocyte microvilli: a role for the extracellular domain in determining membrane localization. J Cell Biol 139: 563–571PubMedGoogle Scholar
  146. 146.
    Cambi A, Joosten B, Koopman M, de Lange F, Beeren I, Torensma R, Fransen JA, Garcia-Parajo M, van Leeuwen FN, Figdor CG (2006) Organization of the integrin LFA-1 in nanoclusters regulates its activity. Mol Biol Cell 17: 4270–4281PubMedGoogle Scholar
  147. 147.
    Hyduk SJ, Chan, Jason R, Duffy ST, Chen M, Peterson MD, Waddell TK, Digby GC, Szaszi K, Kapus A, Cybulsky MI (2007) Phospholipase C, calcium, and calmodulin are critical for {alpha}4ta1 integrin affinity up-regulation and monocyte arrest triggered by chemoattractants. Blood 109: 176–184PubMedGoogle Scholar
  148. 148.
    Chan JR, Hyduk SJ, Cybulsky MI (2000) Alpha 4 beta 1 integrin/VCAM-1 interaction activates alpha L beta 2 integrin-mediated adhesion to ICAM-1 in human T cells. J Immunol 164: 746–753PubMedGoogle Scholar
  149. 149.
    Rose DM, Liu S, Woodside DG, Han J, Schlaepfer DD, GinsbergT MH (2003) Paxillin binding to the alpha 4 integrin subunit stimulates LFA-1 (integrin alpha L beta 2)-dependent T cell migration by augmenting the activation of focal adhesion kinase/proline-rich tyrosine kinase-2. J Immunol 170: 5912–5918PubMedGoogle Scholar
  150. 150.
    Chuluyan HE, Osborn L, Lobb R, Issekutz AC (1995) Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/ CD29)-dependent monocyte transendothelial migration. J Immunol 155: 3135–3134PubMedGoogle Scholar
  151. 151.
    Meerschaert J, Furie MB (1995) The adhesion molecules used by monocytes for migration across endothelium include CDlla/CD18, CDllb/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium. J Immunol 154: 4099–4112PubMedGoogle Scholar
  152. 152.
    Liu S, Thomas SM, Woodside DG, Rose DM, Kiosses WB, Pfaff M, Ginsberg MH (1999) Binding of paxillin to alpha4 integrins modifies integrin-dependent biological responses. Nature 402: 676–681PubMedGoogle Scholar
  153. 153.
    Liu S, Ginsberg MH (2000) Paxillin binding to a conserved sequence motif in the alpha 4 integrin cytoplasmic domain. J Biol Chem 275: 22736–22742PubMedGoogle Scholar
  154. 154.
    Han J, Liu S, Rose DM, Schlaepfer DD, McDonald H, Ginsberg MH (2001) Phosphorylation of the integrin alpha 4 cytoplasmic domain regulates paxillin binding. J Biol Chem 276: 40903–40909PubMedGoogle Scholar
  155. 155.
    Hyduk SJ, Oh J, Xiao H, Chen M, Cybulsky MI (2004) Paxillin selectively associates with constitutive and chemoattractant-induced high-affinity alpha4betal integrins: implications for integrin signaling. Blood 104: 2818–2824PubMedGoogle Scholar
  156. 156.
    Liu S, Kiosses WB, Rose DM, Slepak M, Salgia R, Griffin JD, Turner CE, Schwartz MA, Ginsberg MZH (2002) A fragment of paxillin binds the alpha 4 integrin cytoplasmic domain (tail) and selectively inhibits alpha 4-mediated cell migration. J Biol Chem 277: 20887–20894PubMedGoogle Scholar
  157. 157.
    Goldfinger LE, Han J, Kiosses WB, Howe AK, Ginsberg MH (2003) Spatial restriction of alpha4 integrin phosphorylation regulates lamellipodial stability and alpha4betaldependent cell migration. J Cell Biol 162: 731–741PubMedGoogle Scholar
  158. 158.
    Nishiya N, Kiosses WB, Han J, Ginsberg MH (2005) An alpha(4) integrin-paxillin-Arf-GAP complex restricts Rac activation to the leading edge of migrating cells. Nat Cell Biol 7: 343–352PubMedGoogle Scholar
  159. 159.
    Feral CC, Rose DM, Han J, Fox N, Silverman GJ, Kaushansky K, Ginsberg MH (2006) Blocking the alpha4 integrin paxillin interaction selectively impairs mononuclear leukocyte recruitment to an inflammatory site. J Clin Invest 116: 715–723PubMedGoogle Scholar
  160. 160.
    Alon R, Feigelson SW, Manevich E, Rose DM, Schmitz J, Overby DR, Winter E, Grabovsky V, Shinder V, Matthews BD et al (2005) {alpha}4ta1-dependent adhesion strengthening under mechanical strain is regulated by paxillin association with the {alpha}4-cytoplasmic domain. J Cell Biol 171: 1073–1084PubMedGoogle Scholar
  161. 161.
    Han J, Rose DM, Woodside DG, Goldfinger LE, Ginsberg MH (2003) Integrin alpha 4 beta 1-dependent T cell migration requires both phosphorylation and dephosphorylation of the alpha 4 cytoplasmic domain to regulate the reversible binding of paxillin. J Biol Chem 278: 34845–34853PubMedGoogle Scholar
  162. 162.
    Lim CJ, Han J, Yousefi N, Ma Y, Amieux PS, McKnight GS, Taylor SS, Ginsberg MH (2007) Alpha4 integrins are type I cAMP-dependent protein kinase-anchoring proteins. Nat Cell Biol 9: 415–421PubMedGoogle Scholar
  163. 163.
    Wong T, Hyduk SJ, Cybulsky MI (2007) Calcineurin, a serine/threonine phosphatase, is required for GPCR-triggered association of paxillin, a cytoplasmic adapter protein, with high affinity alpha 4ta1 integrins in U937 cells. FASEB J 21: A126–a.Google Scholar
  164. 164.
    Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, Boren J (2002) Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417: 750–754PubMedGoogle Scholar
  165. 165.
    Glas CK, Witztum JL (2001) Atherosclerosis, the road ahead. Cell 104: 503–516Google Scholar
  166. 166.
    Steinberg D (2002) Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 8: 1211–1217PubMedGoogle Scholar
  167. 167.
    Cybulsky MI, Gimbrone MA Jr (1991) Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251: 788–791PubMedGoogle Scholar
  168. 168.
    Li H, Cybulsky MI, Gimbrone MA Jr, Libby P (1993) An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 13: 197–204PubMedGoogle Scholar
  169. 169.
    Sakai A, Kume N, Nishi E, Tanoue K, Miyasaka M, Kita T (1997) P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimai accumulation of macrophages and T lymphocytes. Arterioscler Thromb Vasc Biol 17: 310–316PubMedGoogle Scholar
  170. 170.
    Iiyama K, Hajra L, Iiyama M, Li H, Di Chiara M, Medoff BD, Cybulsky MI (1999) Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 85: 199–207PubMedGoogle Scholar
  171. 171.
    Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R (1998) Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoEdeficient mouse. Arterioscler Thromb Vasc Biol 18: 842–851PubMedGoogle Scholar
  172. 172.
    Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR (1992) Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 140: 665–673PubMedGoogle Scholar
  173. 173.
    Printseva O, Peclo MM, Gown AM (1992) Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol 140: 889–896PubMedGoogle Scholar
  174. 174.
    Wood KM, Cadogan MD, Ramshaw AL, Parums DV (1993) The distribution of adhesion molecules in human atherosclerosis. Histopathology 22: 437–444PubMedGoogle Scholar
  175. 175.
    van der Wal AC, Das PK, Tigges AJ, Becker AE (1992) Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 141: 1427–1433PubMedGoogle Scholar
  176. 176.
    Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A (1993) The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 171: 223–229PubMedGoogle Scholar
  177. 177.
    O’Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin CD et al (1993) Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92: 945–951Google Scholar
  178. 178.
    Cybulsky MI, Charo IF (2005) Leukocytes, adhesion molecules and chemokines in atherothrombosis. In: V Fuster, EJ Topol, EG Nabel (eds): Atherothrombosis and Coronary Artery Disease, 2nd edition. Lippincott Williams & Wilkins, Philadelphia, 487–504Google Scholar
  179. 179.
    Dansky HM, Barlow CB, Lominska C, Sikes JL, Kao C, Weinsaft J, Cybulsky MI, Smith JD (2001) Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler Thromb Vasc Biol 21: 1662–1667PubMedGoogle Scholar
  180. 180.
    Shih PT, Brennan ML, Vora DK, Territo MC, Strahl D, Elices MJ, Lusis AJ, Berliner JA (1999) Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. Circ Res 84: 345–351PubMedGoogle Scholar
  181. 181.
    Cannella B, Raine CS (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 37: 424–435PubMedGoogle Scholar
  182. 182.
    Barten DM, Ruddle NH (1994) Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J Neuroimmunol 51: 123–133PubMedGoogle Scholar
  183. 183.
    Engelhardt B, Laschinger M, Schulz M, Samulowitz U, Vestweber D, Hoch G (1998) The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. J Clin Invest 102: 2096–2105PubMedGoogle Scholar
  184. 184.
    Wilkinson LS, Edwards JC, Poston RN, Haskard DO (1993) Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium. Lab Invest 68: 82–88PubMedGoogle Scholar
  185. 185.
    Furuzawa-Carballeda J, Alcocer-Varela J (1999) Interleukin-8, interleukin-10, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression levels are higher in synovial tissue from patients with rheumatoid arthritis than in osteoarthritis. Scand J Immunol 50: 215–222PubMedGoogle Scholar
  186. 186.
    Morales-Ducret J, Wayner E, Elices MJ, Alvaro-Gracia JM, Zvaifler NJ, Firestein GS (1992) Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol 149: 1424–1431PubMedGoogle Scholar
  187. 187.
    Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeb J et al (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36: 1681–1690PubMedGoogle Scholar
  188. 188.
    Schrepfer S, Deuse T, Schafer H, Reichenspurner H (2005) FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival. Transpl Int 18: 215–220PubMedGoogle Scholar
  189. 189.
    Goebeler M, Roth J, Brocker EB, Sorg C, Schulze-Osthoff K (1995) Activation of nuclear factor-kappa B and gene expression in human endothelial cells by the common haptens nickel and cobalt. J Immunol 155: 2459–2467PubMedGoogle Scholar
  190. 190.
    Viemann D, Schmidt M, Tenbrock K, Schmid S, Muller V, Klimmek K, Ludwig S, Roth J, Goebeler M (2007) The contact allergen nickel triggers a unique inflammatory and proangiogenic gene expression pattern via activation of NF-kappaB and hypoxia-inducible factor-1 alpha. J Immunol 178: 3198–3207PubMedGoogle Scholar
  191. 191.
    McHale JF, Harari OA, Marshall D, Haskard DO (1999) Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-alpha. J Immunol 162: 1648–1655PubMedGoogle Scholar
  192. 192.
    Leca G, Mansur SE, Bensussan A (1995) Expression of VCAM-1 (CD106) by a subset of TCR gamma delta-bearing lymphocyte clones. Involvement of a metalloprotease in the specific hydrolytic release of the soluble isoform. J Immunol 154: 1069–1077PubMedGoogle Scholar
  193. 193.
    Garton KJ, Gough PJ, Philalay J, Wille PT, Blobel CP, Whitehead RH, Dempsey PJ, Raines EW (2003) Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J Biol Chem 278: 37459–37464PubMedGoogle Scholar
  194. 194.
    Hummel V, Kallmann BA, Wagner S, Fuller T, Bayas A, Tonn JC, Benveniste EN, Toyka KV, Rieckmann P (2001) Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. J Neuropathol Exp Neurol 60: 320–327PubMedGoogle Scholar
  195. 195.
    Singh RJ, Mason JC, Lidington EA, Edwards DR, Nuttall RK, Khokha R, Knauper V, Murphy G, Gavrilovic J (2005) Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Cardiovasc Res 67: 39–49PubMedGoogle Scholar
  196. 196.
    Matsuno O, Miyazaki E, Nureki S, Ueno T, Kumamoto T, Higuchi Y (2006) Role of ADAM8 in experimental asthma. Immunol Lett 102: 67–73PubMedGoogle Scholar
  197. 197.
    Matsuno O, Miyazaki E, Nureki S, Ueno T, Ando M, Ito K, Kumamoto T, Higuchi Y (2006) Elevated soluble ADAM8 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia. Int Arch Allergy Immunol 142: 285–290PubMedGoogle Scholar
  198. 198.
    Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ (2001) Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98: 1289–1297PubMedGoogle Scholar
  199. 199.
    Härtung HP, Reiners K, Archelos JJ, Michels M, Seeldrayers P, Heidenreich F, Pflughaupt KW, Toyka KV (1995) Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann Neurol 38: 186–193PubMedGoogle Scholar
  200. 200.
    Mossner R, Fassbender K, Kuhnen J, Schwartz A, Hennerici M (1996) Vascular cell adhesion molecule — a new approach to detect endothelial cell activation in MS and encephalitis in vivo. Acta Neurol Scand 93: 118–122Google Scholar
  201. 201.
    Dore-Duffy P, Newman W, Balabanov R, Lisak RP, Mainolfi E, Rothlein R, Peterson M (1995) Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol 37: 55–62PubMedGoogle Scholar
  202. 202.
    Droogan AG, McMillan SA, Douglas JP, Hawkins SA (1996) Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1. J Neuroimmunol 64: 185–191PubMedGoogle Scholar
  203. 203.
    Matsuda M, Tsukada N, Miyagi K, Yanagisawa N (1995) Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-1-associated myelopathy. J Neuroimmunol 59: 35–40PubMedGoogle Scholar
  204. 204.
    Calabresi PA, Tranquill LR, Dambrosia JM, Stone LA, Maloni H, Bash CN, Frank JA, McFarland HF (1997) Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b. Ann Neurol 41: 669–674PubMedGoogle Scholar
  205. 205.
    Matusevicius D, Kivisakk P, Navikas W, Tian W, Soderstrom M, Frednkson S, Link H (1998) Influence of IFN-beta 1b (Betaferon) on cytokine mRNA profiles in blood mononuclear cells and plasma levels of soluble VCAM-1 in multiple sclerosis. Eur J Neurol 5: 265–275PubMedGoogle Scholar
  206. 206.
    Jones SC, Banks RE, Haidar A, Gearing AJ, Hemingway IK, Ibbotson SH, Dixon MF, and Axon AT (1995) Adhesion molecules in inflammatory bowel disease. Gut 36: 724–730PubMedGoogle Scholar
  207. 207.
    Goke M, Hoffmann JC, Evers J, Kruger H, Manns MP (1997) Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease. J Gastroenterol 32: 480–486PubMedGoogle Scholar
  208. 208.
    Wellicome SM, Kapahi P, Mason JC, Lebranchu Y, Yarwood H, Haskard DO (1993) Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 92: 412–418PubMedGoogle Scholar
  209. 209.
    Clausen P, Jacobsen P, Rossing K, Jensen JS, Parving HH, Feldt-Rasmussen B (2000) Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabet Med 17: 644–649PubMedGoogle Scholar
  210. 210.
    Ikeda Y, Fujimoto T, Ameno M, Shiiki H, Dohi K (1998) Relationship between lupus nephritis activity and the serum level of soluble VCAM-1. Lupus 7: 347–354PubMedGoogle Scholar
  211. 211.
    Molad Y, Miroshnik E, Sulkes J, Pitlik S, Weinberger A, Monselise Y (2002) Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage. Clin Exp Rheumatol 20: 403–406PubMedGoogle Scholar
  212. 212.
    Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Allenberg J, Kubier W, Bode C (1997) Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 17: 505–512PubMedGoogle Scholar
  213. 213.
    Lang T, Krams SM, Villanueva JC, Cox K, So S, Martinez OM (1995) Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection. Transplantation 59: 584–589PubMedGoogle Scholar
  214. 214.
    Lederer SR, Friedrich N, Regenbogen C, Getto R, Toepfer M, Sitter T (2003) Noninvasive monitoring of renal transplant recipients: urinary excretion of soluble adhesion molecules and of the complement-split product C4d. Nephron Clin Tract94: c19–26Google Scholar
  215. 215.
    Wu YW, Lee CM, Lee YT, Wang SS, Huang PJ (2003) Value of circulating adhesion molecules in assessing cardiac allograft vasculopathy. J Heart Lung Transplant 22: 1284–1287PubMedGoogle Scholar
  216. 216.
    O’Hanlon DM, Fitzsimons H, Lynch J, Tormey S, Malone C, Given HF (2002) Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer 38: 2252–2257PubMedGoogle Scholar
  217. 217.
    Silva HC, Garcao F, Coutinho EC, De Oliveira CF, Regateiro FJ (2006) Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells. Neoplasma 53: 538–543PubMedGoogle Scholar
  218. 218.
    Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Sekara E, Michail P, Rosenberg T, Diamantis T (2003) Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients. Am J Gastroenterol 98: 478–485PubMedGoogle Scholar
  219. 219.
    Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Kremmyda A, Bramis I, Tsigris C (2001) Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur J Cancer 37: 2392–2397PubMedGoogle Scholar
  220. 220.
    Coskun U, Sancak B, Sen I, Bukan N, Tufan MA, Gulbahar O, Sozen S (2006) Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages. Int Immunopharmacol 6: 672–677PubMedGoogle Scholar
  221. 221.
    Christiansen I, Sundstrom C, Totterman TH (1998) Elevated serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) closely reflect tumour burden in chronic B-lymphocytic leukaemia. Br J Haematol 103: 1129–1137PubMedGoogle Scholar
  222. 222.
    Christiansen I, Sundstrom C, Kalkner KM, Bring J, Totterman TH (1998) Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin’s lymphomas. Eur J Haematol 61: 311–318PubMedGoogle Scholar
  223. 223.
    Kamezaki S, Kurozawa Y, Iwai N, Hosoda T, Okamoto M, Nose T (2005) Serum levels of soluble ICAM-1 and VCAM-1 predict pre-clinical cancer. Eur J Cancer 41: 2355–2359PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2007

Authors and Affiliations

  • Sharon J. Hyduk
    • 1
  • Myron I. Cybulsky
    • 1
  1. 1.Department of Laboratory Medicine and PathobiologyUniversity of Toronto, Toronto General Research InstituteTorontoCanada

Personalised recommendations